AFT Pharmaceuticals, Ltd.
AFT Pharmaceuticals, Ltd.
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain | Acute Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Phase 3 | 2026-09-16 | NCT07225634 | |
| A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia | Anemia, Hypochromic, Hemic and Lymphatic Diseases, Iron Deficiencies, Nutritional and Metabolic Diseases, anemia, hematologic disorder, iron deficiency anemia, iron metabolism disease, metabolic disease | Not yet recruiting | Phase 3 | 2026-08-20 | NCT07687784 | |
| Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains | Neoplasms by Histologic Type, capillary hemangioma, hemangioma, neoplasm, vascular cancer | Not yet recruiting | Phase 2 | 2026-07-01 | NCT07436611 | |
| A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Not yet recruiting | Phase 3 | 2026-07-01 | NCT07225140 |